Novavax Inc (NVAX)

$4.34 0.27 (6.63%)

10:18 EDT NVAX Stock Quote Delayed 30 Minutes

Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?

By Rich Duprey, InvestorPlace Contributor Apr 9, 2024

These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around.

7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode

The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar

It’s Time! 3 Failing Biotech Stocks to Sell Right Now

Volume:

Previous Close -

Market Cap 323.26M

PE Ratio -0.78

EPS -5.56

Volume (Avg. Vol.) 998,915

Day's Range $4.08 - $4.36

52-Week Range $3.53 - $10.30

Dividend & Yield N/A (N/A)

NVAX Stock Predictions, Articles, and Novavax Inc News

From InvestorPlace
From the Web

Exit Alert: 3 Overhyped Stocks With Weak Fundamentals

By Faisal Humayun, InvestorPlace Contributor Mar 5, 2024

These are overhyped stocks to sell as they represent companies with weak fundamentals and prospects of cash burn.

NVAX Stock Alert: 9 Reasons Why Novavax Investors Are So Disappointed Today

By William White, InvestorPlace Writer Feb 28, 2024

Novavax stock is falling hard on Wednesday as NVAX investors react to it missing estimates for Q4 and posting weak guidance for 2024!

NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute

By William White, InvestorPlace Writer Feb 22, 2024

Novavax stock is climbing higher on Thursday as investors in NVAX shares react to it reaching a $475 million settlement with Gavi.

Exit Now! 3 Biotech Stocks to Sell in February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 21, 2024

These biotech stocks to sell represent incredibly risky bets, amidst the sector's volatility and looming economic unpredictability.

Get Rich Quick With These 3 Stocks to Buy Now

By Josh Enomoto, InvestorPlace Contributor Feb 15, 2024

If you’re looking for stocks to buy now that will give you robust returns inside of one year, you’ve come to the right place. Here,…

3 Doomed Biotech Stocks to Dump Before They Dive: February 2024

By Muslim Farooque, InvestorPlace Contributor Feb 11, 2024

Spot the looming risks in the biotech sector and avoid these three doomed biotech stocks likely to burn shareholder value significantly.

Novavax Layoffs 2024: What to Know About the Latest NVAX Job Cuts

By Josh Enomoto, InvestorPlace Contributor Jan 31, 2024

The Novavax layoffs are coming for 12% of the company's global workforce. However, NVAX stock itself could shock the market.

Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold

By Faisal Humayun, InvestorPlace Contributor Jan 15, 2024

Be sure to sell these meme stocks as they represent fundamentally weak businesses that will continue to erode in value.

Time to Buy These 3 Stocks That Just Hit a 52-Week Low?

By Rich Duprey, InvestorPlace Contributor Jan 15, 2024

Sometimes buying stocks at a 52-week low is a chance to buy a good company at great prices but you need to see if the business is busted.

Smart Shorts: 7 Meme Stocks to Bet Against in 2024

By Thomas Niel, InvestorPlace Contributor Dec 28, 2023

These seven meme stocks have surged as speculators declare "the coast is clear," but a big reversal for each of them may be forthcoming.

3 Heavily Shorted Stocks That Still Won’t See a Squeeze

By Faisal Humayun, InvestorPlace Contributor Dec 25, 2023

These are the heavily shorted stocks to avoid as they are likely to continue trending lower on the back of very weak fundamentals.

3 Meme Stocks That Could Fade Away in 2024

By Faisal Humayun, InvestorPlace Contributor Dec 18, 2023

These are the meme stocks to avoid or sell as they have extremely weak fundamentals and are unlikely to recover from a financial perspective.

3 Short-Squeeze Stocks That Could Take Off Before Year-End

By Shane Neagle, InvestorPlace Contributor Nov 30, 2023

These three short-squeeze stocks are seeing high short interest. They each could see a year-end short squeeze and notable market moves.

7 Dangerous Stocks to Avoid No Matter What

By Thomas Niel, InvestorPlace Contributor Nov 1, 2023

Despite arguments to the contrary, stay away from each of these seven stocks to avoid, as each carries substantial downside risk.

Novavax (NVAX) Stock Slides Despite Vaccine Availability

By Josh Enomoto, InvestorPlace Contributor Oct 13, 2023

Although Novavax’s non-mRNA vaccine being available broadly represents good news, NVAX stock suffered due to unfavorable timing.

3 Pharma Stocks to Dump Before the Damage Is Done

By Alex Sirois, InvestorPlace Contributor Oct 8, 2023

There's never a shortage of pharma stocks to sell due to the nature of the sector, especially when compounded by current fears.

Short Sellers Are Betting Against Novavax (NVAX) Stock

By Dana Blankenhorn, InvestorPlace Contributor Oct 4, 2023

Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.

NVAX, AI, CVNA: The 3 Most Shorted Stocks This Month

By Josh Enomoto, InvestorPlace Contributor Sep 28, 2023

With the market suffering losses due to broader headwinds, hedge funds have targeted the most shorted stocks for cynical profits.

Ticking Time Bombs: 3 Biotech Stocks to Dump Before the Damage Is Done

By Chandler Capital, InvestorPlace Contributor Sep 26, 2023

Investors should do their due diligence before investing in these three risky, unreliable and unprofitable biotech stocks.

7 Biotech Stocks to Sell in September Before They Crash & Burn

By Alex Sirois, InvestorPlace Contributor Sep 6, 2023

Biotech stocks to sell are a dime a dozen and very risky which is why September is a great time to offload them.

Novavax Inc (NVAX)

Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?

7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode

The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar

It’s Time! 3 Failing Biotech Stocks to Sell Right Now

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novavax Inc (NVAX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVAX Stock Predictions, Articles, and Novavax Inc News

Subscriber Sign in